Updated on 4 June 2012
A third PSU, Central Research Institute in Kasauli, Himachal Pradesh, too has been revived with the unit producing 134.55 lakh doses of diptheria, pertussis, and tetanus (DPT) vaccine since February 2010 when its suspension of license was revoked. The PII in Coonor will release its first set of anti-rabies vaccines in the market in June 2012. Sources told BioSpectrum that about 39.5 million doses of DPT vaccines will be released in a year by the PII.
The BCGVL in Guindy, which will produce the BCG vaccine, is still to commence manufacturing activities. Hence, the BCG vaccine, which protects against tuberculosis, is being supplied by the Serum Institute of India (SII), Pune, for now. All the three units have also been asked to ensure that their production lines are made fully compliant with the GMP standards within three years.